Lung Cancer: Radiotherapy

(asked on 11th March 2019) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans he has to support the extension of stereotactic body radiation therapy services for lung cancer in radiotherapy centres throughout England.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 14th March 2019

There are 25 providers, two of which work in partnership, of stereotactic body radiation therapy, which is called Stereotactic Ablative Radiotherapy (SABR). Currently, SABR is routinely commissioned to treat early non-small cell lung cancer in patients that are not suitable for surgery.

SABR is currently restricted to these 25 centres in England whilst evidence of clinical effectiveness emerges. This is regularly reviewed by NHS England’s national specialised commissioning team and was last reviewed during 2016/17. It is expected that access will be reviewed again over the course of 2019/20 and 2020/21. However, this will be dependent on the emergence of clinical evidence and the development of new NHS England clinical commissioning policy.

Reticulating Splines